Name | 7-allyl-8-oxoguanosine |
---|---|
Synonyms |
7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95
7-allyl-8-oxo-G Loxoribine 7-Allyl-7,8-dihydro-8-oxoguanosine MFCD00867591 |
Description | Loxoribine (7-Allyl-8-oxoguanosine) is a guanosine analog with anti-viral and anti-tumor activities. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist[1][2][3]. |
---|---|
Related Catalog | |
Target |
TLR7[1] |
In Vitro | Loxoribine induces maturation of human monocyte-derived dendritic cells DCs and stimulates their Th-1- and Th-17-polarizing capability[2]. Loxoribine (250 μM; 48 hours) stimulates maturation of MoDCs as shown by up-regulation of CD80, CD83, CD40, CD54 and CCR7[2]. loxoribine activates cells of the innate immune system selectively via the Toll-like receptor (TLR) 7/MyD88-dependent signaling pathway[1]. |
In Vivo | Loxoribine (2 mg; s.c.or i.v.) activates murine natural killer (NK) cells in vivo[3]. Animal Model: 8-12 weeks male CBA/J mice[3] Dosage: 2 mg Administration: Subcutaneous or intravenous injection Result: activates murine natural killer (NK) cells in vivo. |
References |
Density | 1.92g/cm3 |
---|---|
Boiling Point | 591.8ºC at 760mmHg |
Melting Point | 227-230ºC(lit.) |
Molecular Formula | C13H17N5O6 |
Molecular Weight | 339.30400 |
Flash Point | 311.7ºC |
Exact Mass | 339.11800 |
PSA | 168.62000 |
Vapour Pressure | 1.81E-16mmHg at 25°C |
Index of Refraction | 1.812 |
Storage condition | Desiccate at +4°C |
WGK Germany | 3 |
---|
~99% 121288-39-9 |
Literature: WO2013/67597 A1, ; Page/Page column 108 ; |
~% 121288-39-9 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 21 p. 3561 - 3578 |
~% 121288-39-9 |
Literature: Nucleosides and Nucleotides, , vol. 13, # 1-3 p. 551 - 562 |
Precursor 4 | |
---|---|
DownStream 0 |